MedTrace Logo

Lung HIV Disease in a Large Cohort-Pitt

NCT01326572 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 189

Last updated 2025-08-26

No results posted yet for this study

Summary

HIV-infected patients have an increased incidence of emphysema compared to non-HIV-infected patients, and it has been hypothesized that this accelerated disease progression is the result of one or more latent infections that amplifies the pulmonary inflammatory response. The investigators will examine the prevalence and progression of emphysema in subjects with and without HIV and determine risk factors for emphysema in this population.

Conditions

  • Pulmonary Disease
  • HIV
  • Emphysema

Sponsors & Collaborators

Principal Investigators

  • Alison Morris-Gimbel, MD, MS · University of Pittsburgh

Eligibility

Min Age
18 Years
Max Age
72 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2016-01-31
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01326572 on ClinicalTrials.gov